A clinico pathological study and management of benign enlargement of prostate
DOI:
https://doi.org/10.18203/2349-2902.isj20180992Keywords:
Benign enlargement of prostate, IPSS score, Post voidal residual urineAbstract
Background: Benign prostatic hyperplasia (BPH) is the non-malignant enlargement of the prostate gland. Prolonged obstructions may eventually lead to acute urinary retention, recurrent urinary tract infection, hematuria, bladder calculi, and renal insufficiency.
Methods: Hundred cases of benign enlargement of prostate were studied from November 2015 to 2016. Patients diagnosed as benign enlargement of prostate by clinical digital rectal examination, investigation like USG were included in this study. Patients with urinary retention due to strictures and urolithiasis, carcinoma were excluded.
Results: Mean age of presentation was 64.4, and 34% were found to be in severe group of IPSS grading. There was a significant co-relation between the PVRU and prostate volume. There were 16% cases of acute urinary retention, 2% cases presented with bladder stones. Benign enlargement of prostate, IPSS score, Post voidal residual urine has a weak correlation with the increasing age as observed.
Conclusions: Benign enlargement of prostate is a disease of elderly with peak incidence in the 5th and 6th decade of life, BPH has co-relation with inguinal hernia, AUR which is 16%. There was no correlation between the age of the patient and the severity of symptoms with respect to IPSS score. There was no correlation between the age of the patient and the severity of symptoms with respect to IPSS score. In present study there was a statistically significant relation were found between prostate volume and post voidal residual urine. Large amount of residual urine is the indication for surgery because it predisposes to infections and stone formation.
References
Miller J, Tarter TH. Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. Clin Interv Aging. 2009;4:251-8.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-9.
Reohrborn GC. Beningn prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. Campbell-Wash urology. 10th ed. Philadelphia: Saunders Esavier. 2012:2576-81.
Curtis NJ. BPH: Costs and treatment outcomes. Am J Manag Care. 2006;12:141-8.
Emberton M, Cornel EB, Bassi PF, Fourcade RO, Gomez JMF, Castro R. Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management. Int J Clin Pract. 2008;62(7):1076-86.
DeLellis RA. The neuroendocrine system and its tumors: an overview. Am J Clin Pathol. 2001;115:5-16.
Lepor H, Williford WO, Barry M. A randomized placebo controlled trial of terazosin and fmasteride monotherapy and terazosin/fmasteride combination therapy in men with clinical benign prostatic hyperplasia. N Engi J Med. 1996;335(8):533-39.
Nicolás JT, Tornero JR, Bañón VP, Server GP, López PC, Pérez MA. Relation between hypertension and clinical cases of benign prostatic hyperplasia. Archivos espanoles de urologia. 2003 May;56(4):355-8.
Li XD. Twenty-eight cases report of transurethral resection of the prostate combined with repair of inguinal hernia. Zhonghua Nan KeXue. 2002;8(2):148-9.
Breum L, Klarskov P, Munck LK, Significance of acute urinary retention due to intravesical obstruction. Scand J Urol Nephrol. 1982;16:21-4.
Klarskov P, Andersen JT, Asmussen CF. Symptoms and signs predictive of the voiding pattern after acute urinary retention in men. Scand J Urol Nephrol. 1987;21:23-8.
Mc Connell JD. Hormonal treatment of benign prostatic hyperplasia. Urol Clin North Am. 1995;22:387-400.
Perrin P, Barnes R, Hadley H, Bergman RT. Forty years of transurethral prostatic resections. The Journal of urology. 1976 Dec 1;116(6):757-8.
Reich O, Gratzke C, Bachmann A. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1);15-6.
Basawaraj NG, Dasan TA, Patil SS. Correlation of sonographic prostate volume with international prostate symptom score in South Indian men. J Urol. 2008;180;(1);15-6.
Kumar M, Khatri SL,Saxena V. Clinicopathological study of prostate lesions. Indian J Basic Applied Med Res. 2016;6(1)695-04.
Gupta A, Gupta D,Raizada A. A hospital based study on reference range of serum prostate specific antigen levels. Indian J Med Res. 2014;140(4):507-12.
Reshma K, Kuthethur S, Manjerekar P, Gopal M. Evaluation of biochemical markers of renal dysfunction in prostate disorders and healthy controls. Int J Biochem Adv Res. 2014;5(9)
Kolman C, Girman CJ, Jacobsen SJ, Lieber MM. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161(1):122-7.
